Terms: = Breast cancer AND POT1, DKFZP586D211, 25913, ENSG00000128513, hPot1, DKFZp586D211
17 results:
1. A
Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
[TBL] [Abstract] [Full Text] [Related]
2.
Jensen MR; Jelsig AM; Gerdes AM; Hölmich LR; Kainu KH; Lorentzen HF; Hansen MH; Bak M; Johansson PA; Hayward NK; Van Overeem Hansen T; Wadt KAW
HGG Adv; 2023 Oct; 4(4):100225. PubMed ID: 37646013
[No Abstract] [Full Text] [Related]
3. Role of TMPRSS4 Modulation in breast cancer Cell Proliferation.
Assani G; Yessoufou A; Xiong Y; Segbo J; Yu X; Zhou F; Zhou Y
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1849-1856. PubMed ID: 31244309
[TBL] [Abstract] [Full Text] [Related]
4. The shieldin complex mediates 53BP1-dependent DNA repair.
Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
[TBL] [Abstract] [Full Text] [Related]
5. Identification, genetic testing, and management of hereditary melanoma.
Leachman SA; Lucero OM; Sampson JE; Cassidy P; Bruno W; Queirolo P; Ghiorzo P
Cancer Metastasis Rev; 2017 Mar; 36(1):77-90. PubMed ID: 28283772
[TBL] [Abstract] [Full Text] [Related]
6. pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.
Gu P; Wang Y; Bisht KK; Wu L; Kukova L; Smith EM; Xiao Y; Bailey SM; Lei M; Nandakumar J; Chang S
Oncogene; 2017 Apr; 36(14):1939-1951. PubMed ID: 27869160
[TBL] [Abstract] [Full Text] [Related]
7. Telomere structure and maintenance gene variants and risk of five cancer types.
Karami S; Han Y; Pande M; Cheng I; Rudd J; Pierce BL; Nutter EL; Schumacher FR; Kote-Jarai Z; Lindstrom S; Witte JS; Fang S; Han J; Kraft P; Hunter DJ; Song F; Hung RJ; McKay J; Gruber SB; Chanock SJ; Risch A; Shen H; Haiman CA; Boardman L; Ulrich CM; Casey G; Peters U; Amin Al Olama A; Berchuck A; Berndt SI; Bezieau S; Brennan P; Brenner H; Brinton L; Caporaso N; Chan AT; Chang-Claude J; Christiani DC; Cunningham JM; Easton D; Eeles RA; Eisen T; Gala M; Gallinger SJ; Gayther SA; Goode EL; Grönberg H; Henderson BE; Houlston R; Joshi AD; Küry S; Landi MT; Le Marchand L; Muir K; Newcomb PA; Permuth-Wey J; Pharoah P; Phelan C; Potter JD; Ramus SJ; Risch H; Schildkraut J; Slattery ML; Song H; Wentzensen N; White E; Wiklund F; Zanke BW; Sellers TA; Zheng W; Chatterjee N; Amos CI; Doherty JA;
Int J Cancer; 2016 Dec; 139(12):2655-2670. PubMed ID: 27459707
[TBL] [Abstract] [Full Text] [Related]
8. A mutation in the pot1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
Calvete O; Martinez P; Garcia-Pavia P; Benitez-Buelga C; Paumard-Hernández B; Fernandez V; Dominguez F; Salas C; Romero-Laorden N; Garcia-Donas J; Carrillo J; Perona R; Triviño JC; Andrés R; Cano JM; Rivera B; Alonso-Pulpon L; Setien F; Esteller M; Rodriguez-Perales S; Bougeard G; Frebourg T; Urioste M; Blasco MA; Benítez J
Nat Commun; 2015 Sep; 6():8383. PubMed ID: 26403419
[TBL] [Abstract] [Full Text] [Related]
9. The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines.
Motevalli A; Yasaei H; Virmouni SA; Slijepcevic P; Roberts T
Breast Cancer Res Treat; 2014 Jun; 145(3):581-91. PubMed ID: 24807106
[TBL] [Abstract] [Full Text] [Related]
10. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variation in telomere maintenance genes, telomere length and breast cancer risk.
Shen J; Terry MB; Liao Y; Gurvich I; Wang Q; Senie RT; Santella RM
PLoS One; 2012; 7(9):e44308. PubMed ID: 22970196
[TBL] [Abstract] [Full Text] [Related]
12. Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.
Shen J; Gammon MD; Terry MB; Bradshaw PT; Wang Q; Teitelbaum SL; Neugut AI; Santella RM
Breast Cancer Res Treat; 2012 Jul; 134(1):393-400. PubMed ID: 22527105
[TBL] [Abstract] [Full Text] [Related]
13. Multiple genetic variants in telomere pathway genes and breast cancer risk.
Shen J; Gammon MD; Wu HC; Terry MB; Wang Q; Bradshaw PT; Teitelbaum SL; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):219-28. PubMed ID: 20056641
[TBL] [Abstract] [Full Text] [Related]
14. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.
Varadi V; Brendle A; Brandt A; Johansson R; Enquist K; Henriksson R; Svenson U; Tavelin B; Roos G; Hemminki K; Lenner P; Försti A
Eur J Cancer; 2009 Nov; 45(17):3008-16. PubMed ID: 19766477
[TBL] [Abstract] [Full Text] [Related]
15. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
[TBL] [Abstract] [Full Text] [Related]
16. Genetic variation in five genes important in telomere biology and risk for breast cancer.
Savage SA; Chanock SJ; Lissowska J; Brinton LA; Richesson D; Peplonska B; Bardin-Mikolajczak A; Zatonski W; Szeszenia-Dabrowska N; Garcia-Closas M
Br J Cancer; 2007 Sep; 97(6):832-6. PubMed ID: 17848914
[TBL] [Abstract] [Full Text] [Related]
17. The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome.
Salhab M; Jiang WG; Newbold RF; Mokbel K
Breast Cancer Res Treat; 2008 May; 109(1):35-46. PubMed ID: 17616810
[TBL] [Abstract] [Full Text] [Related]
